08156 国药科技股份
按盘价 
0.102 +0.002 (+2.000%) | 2023/06 - 末期 港元() | 2022/06 港元() | 2021/06 港元() | 2020/06 港元() | 2019/06 港元() | |
| 经营活动之现金流量 | 4,733,000 | (36,764,000) | (6,211,000) | 23,920,000 | (33,854,000) |
| 投资活动之现金流量 | 2,000 | (85,000) | (5,047,000) | (23,393,000) | 25,000 |
| 融资活动之现金流量 | (4,517,000) | 32,238,000 | 12,455,000 | (299,000) | 36,895,000 |
| 现金及等同现金之增加/(减少) | 218,000 | (4,611,000) | 1,197,000 | 228,000 | 3,066,000 |
| 期初之现金及现金等价物 | 2,991,000 | 7,482,000 | 6,746,000 | 6,646,000 | 4,719,000 |
| 汇率变动之影响 | (1,433,000) | 120,000 | (461,000) | (128,000) | (1,139,000) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | 1,776,000 | 2,991,000 | 7,482,000 | 6,746,000 | 6,646,000 |
| 备注： | 实时报价更新时间为29/04/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | HKD -2,876,000 |
| 增长率 | -- |
| 每股盈利/(亏损) | HKD -0.016 |
| 每股账面资产净值 ($) | HKD -0.960 |